{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ONE&page=87", "query": { "intervention": "ONE", "page": 87 }, "page_size": 10 }, "pagination": { "page": 87, "page_size": 10, "total_count": 21040, "total_pages": 2104, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ONE&page=88&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ONE&page=86&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-09T05:10:48.231Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01882439", "title": "Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Tofacitinib", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 395, "start_date": "2013-08", "completion_date": "2016-04", "has_results": true, "last_update_posted_date": "2017-09-15", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 43, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Glendale, Arizona + 33 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01882439" }, { "nct_id": "NCT02005601", "title": "Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Total Knee Arthroplasty" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Duloxetine 60mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "25 Years to 75 Years" }, "enrollment_count": 106, "start_date": "2013-11", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2017-08-29", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02005601" }, { "nct_id": "NCT04844528", "title": "Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Lymphocytic Leukemia", "Non-melanoma Skin Cancer (NMSC)" ], "interventions": [ { "name": "Nicotinamide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 86, "start_date": "2022-02-25", "completion_date": "2028-08", "has_results": false, "last_update_posted_date": "2025-12-03", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04844528" }, { "nct_id": "NCT01476800", "title": "A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects", "Pharmacokinetics of YM178" ], "interventions": [ { "name": "YM178 OCAS", "type": "DRUG" }, { "name": "Ketoconazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "19 Years to 55 Years" }, "enrollment_count": 24, "start_date": "2006-07", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2015-09-01", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "Lincoln, Nebraska", "locations": [ { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01476800" }, { "nct_id": "NCT03971409", "title": "Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stage III Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer", "Stage IV Breast Cancer", "Invasive Breast Carcinoma", "Recurrent Breast Carcinoma", "Triple-Negative Breast Carcinoma", "Unresectable Breast Carcinoma" ], "interventions": [ { "name": "Anti-OX40 Antibody PF-04518600", "type": "BIOLOGICAL" }, { "name": "Avelumab", "type": "DRUG" }, { "name": "Binimetinib", "type": "DRUG" }, { "name": "Utomilumab", "type": "BIOLOGICAL" }, { "name": "Liposomal Doxorubicin", "type": "DRUG" }, { "name": "Sacituzumab Govitecan", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Laura Huppert, MD, BA", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 145, "start_date": "2019-07-08", "completion_date": "2027-01-31", "has_results": false, "last_update_posted_date": "2026-04-17", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 12, "location_summary": "Birmingham, Alabama • San Francisco, California • Washington D.C., District of Columbia + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Evergreen Park", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03971409" }, { "nct_id": "NCT01390363", "title": "Study of Adolescent Immunization Recall Systems", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Immunization", "Reminder Systems" ], "interventions": [ { "name": "Parent Only Phone Call", "type": "OTHER" }, { "name": "Parent and Adolescent Phone Call", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "FEMALE", "summary": "13 Years to 17 Years · Female only" }, "enrollment_count": 420, "start_date": "2010-05-01", "completion_date": "2011-07-31", "has_results": false, "last_update_posted_date": "2017-04-13", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01390363" }, { "nct_id": "NCT00781287", "title": "Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Human Immunodeficiency Virus" ], "interventions": [ { "name": "3-drug anti-HIV therapy", "type": "DRUG" }, { "name": "Raltegravir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2009-02", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2013-08-12", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00781287" }, { "nct_id": "NCT01856712", "title": "Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alcohol Dependence" ], "interventions": [ { "name": "Naltrexone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2013-05", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2019-03-05", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01856712" }, { "nct_id": "NCT00225381", "title": "Gas Kinetics and Metabolism in Anesthesia During Non Steady State", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Anesthetized Healthy Patients (ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries", "Anesthetized Patient With Severe Systemic Disease (ASA 3 or 4)" ], "interventions": [ { "name": "connection of measuring device to anesthesia circuit", "type": "DEVICE" }, { "name": "drawing of blood sample through an arterial line, placed according to clinical criteria by primary anesthesia team", "type": "PROCEDURE" }, { "name": "changing operating room bed position (head down and up position)", "type": "PROCEDURE" }, { "name": "adding PEEP during anesthesia", "type": "PROCEDURE" }, { "name": "placement of esophageal Doppler for cardiac output measurements", "type": "PROCEDURE" }, { "name": "Humidity sensor", "type": "DEVICE" }, { "name": "A mixing chamber (bymixer)", "type": "DEVICE" }, { "name": "Pneumotachometer cuvette", "type": "DEVICE" }, { "name": "Mass spectrometer sampling port", "type": "DEVICE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2005-08", "completion_date": "2012-01-13", "has_results": false, "last_update_posted_date": "2021-03-23", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00225381" }, { "nct_id": "NCT00795665", "title": "Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glioma" ], "interventions": [ { "name": "bevacizumab", "type": "DRUG" }, { "name": "carmustine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2008-06", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2020-05-12", "last_synced_at": "2026-11-09T05:10:48.231Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00795665" } ] }